An increasing number of innovative potential treatments for Alzheimer’s disease are advancing in the clinical pipeline. However, the value frameworks and health technology assessments of today may create challenges that inhibit sustainable patient access. Among those who may be hardest hit are older adults, women, and racial and ethnic minorities. However, there may be opportunities to improve the situation by modifying value frameworks to incorporate issues of equity and inclusion. Doing so will help to build a more ethical ecosystem and help to ensure greater access to innovation for those who might otherwise face barriers. This webinar will define how Alzheimer’s disease affects underserved communities; share opportunities to create more equitable, ethical, and inclusive value frameworks; and educate on the community’s role in solving this problem.
Learning Objectives:
- Understand the differential impact of Alzheimer’s disease on underserved groups
- Learn how current value framework could be extended to capture equity
- How stakeholders can collaborate to implement equity considerations into value assessment
Click here for additional information and registration details.
